COMPOUNDS OF FORMULA (I) ARE USEFUL IN TREATING, CONDITIONS OI DISORDERS PREVENTED BY OR AMELIORATED BY HISTAMINE-3 RECEPTOR LIGANDS. ALSO DISCLOSED ARE PHARMACEUTICAL COMPOSITIONS COMPRISING THE HISTAMINE-3 RECEPTOR LIGANDS, METHODS FOR USING SUCH COMPOUNDS AND COMPOSITIONS, AND A PROCESS FOR PREPARING COMPOUNDS WITHIN THE SCOPE OF FORMULA (I).